Navigation Links
Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad
Date:9/7/2011

eed with limited treatment options.

About Lesinurad

Lesinurad is our most advanced product candidate for the chronic treatment of gout.  Lesinurad is an oral, once-daily inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.  Approximately 90 percent of gout patients are considered to be under-excretors of uric acid, and recent studies have shown that defects in renal transporters have been genetically linked to gout.  Consequently, increasing renal excretion of uric acid by moderating URAT1 transporter activity may provide the most physiologically appropriate means of reducing sUA levels.  In addition, because increasing the excretion of uric acid is additive to the effects of drugs known as xanthine oxidase inhibitors that decrease the production of uric acid, including allopurinol and febuxostat, lesinurad in combination with such drugs has the potential to treat the significant portion of the gout population that is not adequately treated with existing therapies.

Lesinurad has been evaluated as a single agent and in combination with the approved xanthine oxidase inhibitors, allopurinol and febuxostat.  Over 500 people have received lesinurad in Phase 1 and 2 clinical trials.

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. Lesinurad, our lead product candidate for the chronic treatment of gout, is a once-daily, oral inhibitor of the URAT1 transporter.  We have completed Phase 2b clinical studies of lesinurad and continue to advance the drug in longer term extensions of these studies.  In support of our Phase 3 program we are currently advancing lesinurad in a multinational interventional study designed to identify gout patients who can then enroll into our main Phase 3 studies. 
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
2. Ardea Biosciences to Present at Upcoming Investor Conferences
3. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
4. Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results
5. Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
6. Ardea Biosciences Announces Exercise in Full of Overallotment Option for Common Stock Offering
7. Ardea Biosciences Prices Public Offering of Common Stock
8. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
9. Ardea Biosciences to Present at Two Upcoming Investor Conferences
10. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
11. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Shimadzu Scientific ... UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength scanning from ... is ideal for applications in a variety of ... , The user-friendly UV-1280 enables intuitive operation, while ...
(Date:1/22/2015)... 2015 The laboratory information management systems ... a number of technological advancements due to factors such ... need to integrate healthcare systems, and increasing government support ... system integration. Key players in the market focus on ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Dr. Greg Leyer ... 12th annual Scripps Natural Supplements Pre-Conference seminar on probiotics in ... is an annual continuing education conference for health care professionals. ... included the topic of probiotics in health. Dr. Leyer spoke ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... Mammalian whole blood is a widely ... for molecular assays due to abundant genetic information as , ... isolation from whole blood is challenging, ... MagMAX-96 Blood RNA Isolation Kit uses strong denaturing , ...
... Mike Byrom, Ambion, Inc., ... and more researchers are conducting siRNA experiments to , ... effect is only evaluated at the level of mRNA, but this , ... most siRNA studies--the , biological ...
... David Brown (Senior Scientist, , ... The realization that RNA interference (RNAi) , ... studies occurred with the seminal Elbashir et al. (1) , ... (siRNAs) in mammalian cells in 2001. In less than two years, , ...
Cached Biology Technology:Robust High Throughput RNA Isolation from Blood Samples 2Robust High Throughput RNA Isolation from Blood Samples 3Robust High Throughput RNA Isolation from Blood Samples 4RNAi: Get the Whole Story 2RNAi: Get the Whole Story 3RNAi: Get the Whole Story 4RNAi: Get the Whole Story 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 2RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 3RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 4RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 6RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 8
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... , Using DNA samples and images from Earth-orbiting ... Society, the American Museum of Natural History, and ... franciscanaa poorly known coastal dolphin species of eastern ... conserve them. The study, one of ...
... The first trial of an important new combination ... with radiation in lung cancer has delivered promising results, ... Conference. The results of the Phase I ... drugs, is well-enough tolerated to allow it to be ...
... Envisat on Thursday at 16:23 UTC, oil from the massive ... a dark blue swirl advancing toward the Louisiana coast. ... than first estimated had spread to just under 5 ... are being made by all available resources to help avert ...
Cached Biology News:Satellites, DNA and dolphins 2Satellites, DNA and dolphins 3Satellites, DNA and dolphins 4First trial of pemetrexed with radiation and chemo in lung cancer shows promising results 2Oil spill in the Gulf of Mexico nears the coast 2
... The ULS cDNA Synthesis and Labeling Kit ... hybridization experiments. First unmodified cDNA is made ... cDNA using an Oligo(dT) primer. Unlike other ... used in the reverse transcription reaction. This ...
... 'The DNAscope LM is a high quality ... technology for optimal background rejection and spatial resolution. ... is the only low cost microarray scanner that ... excitation sources. Main Features: Includes ...
AC input: 50-60 Hz 115-120 V...
MAb to Myoglobin Cardiac...
Biology Products: